A carregar...
Feminizing Hormone Therapy Prescription Patterns and Cardiovascular Risk Factors in Aging Transgender Individuals in Australia
CONTEXT: The safety and efficacy of feminizing hormone therapy in aging transgender (trans) individuals is unclear. Current recommendations suggest transdermal estradiol beyond the age of 45 years, especially if cardiometabolic risk factors are present. OBJECTIVE: To evaluate feminizing hormone ther...
Na minha lista:
| Publicado no: | Front Endocrinol (Lausanne) |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8313995/ https://ncbi.nlm.nih.gov/pubmed/34326812 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.667403 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|